[{"Assets_0_Q2_USD":234141000.0,"CommonStockSharesOutstanding_0_Q2_shares":45949418.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-85109000.0,"NetIncomeLoss_1_Q2_USD":-47164000.0,"NetIncomeLoss_2_Q2_USD":-95115000.0,"StockholdersEquity_0_Q2_USD":155758000.0,"Ticker":"AERI","CIK":"1337553","name":"AERIE PHARMACEUTICALS INC","OfficialName":"Aerie Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"408427417.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]